The U.S. Food and Drug Administration is moving to fast-track reviews of two experimental Merck drugs with ...

Alembic Pharmaceuticals announced that it has received final approval from the US Food & Drug Administration (USFDA) for its abbreviated new drug application (ANDA) for Travoprost Ophthalmic Solution ...

Alphamab Oncology (stock code: 9966.HK) announced that the Investigational New Drug (IND) application for JSKN027, an ...

NCX 470 is currently licensed to Ocumension Therapeutics for China, Korea, and Southeast Asia. According to Nicox, projected ...

Researchers have developed a new antimalarial drug candidate designed to address the growing challenge of drug resistance and ...

The U.S. health regulator has approved GSK's add-on treatment for severe asthma, offering a less frequently dosed option, but ...

New obesity treatments such as 'oral Mounjaro' and 'high-dose Wegovy' are scheduled to be released next year. The U.S. Food ...

Swapnil Shah, Promoter and Managing Director of Senores Pharmaceuticals, said the total market opportunity for the five ANDAs ...

The CNPV program significantly reduces drug review times, necessitating operational shifts for sponsors to meet compressed ...

Researchers in the Nanoscience Center at the University of Jyväskylä, Finland, have developed a pioneering computational ...

AI tools have emerged as a transformative technology to help spot or avert any potential disruptions in the global ...

The FDA has cleared the initiation of a pivotal Phase 3 trial testing pridopidine in people with early, rapidly progressive ...